In today’s episode, we’ll be looking at considerations for Medical Affairs in Rare Disease and Gene Therapy
The transformation is happening now. Discover how Medical Affairs teams are evolving from an executional hub to a strategic pillar, resonating and reconciling the voice of the patient and clinicians, and driving insights to their organization. Using the MAPS Medical Affairs Vision 2030 as our roadmap, experts will discuss the criticality of:
Medical Affairs is increasingly playing a mission-critical role in bringing novel medicines to patients and working as a value-adding partner with R&D and commercial functions in pharma. In this webinar, a roundtable of experienced Medical Affairs leaders will discuss the opportunities and challenges evolving within their field, as well as the impact it can have on delivering great patient outcomes. The webinar will also explore how, while operating at an asset, above-asset and company-mission level, Medical Affairs can act as an organizational lead across the diverse areas of insight and evidence generation, scientific communication and engagement, patient advocacy and more.
This article outlines the aspects of Medical Affairs strategy and launch excellence specific to supporting the development and launch of treatments targeting rare diseases, providing a roadmap for MA teams and organizations undertaking this planning.
In Q&A format, this article summarizes key learnings from a MAPS 2022 Global Annual Meeting panel presented by the Medical Strategy FAWG.
This webinar will be covering:
1. Looking into the future of MA in Japan
a. How to engage more with Patients/Patient Advocacy groups
b. How to bring more value to customers, scientific leaders and health systems
c. How to better engage academia and health authority group through scientific exchange
2. Opportunities for improving effectiveness
a. Differentiation of MSL and Medical Rep roles- how are companies differentiating despite the regulations?
This white paper by the MAPS Executive Consortium synthesizes the views of senior global Medical Affairs leaders to provide a unified vision for the future of Medical Affairs in society, industry, teams and as individuals.
MAPS members represent the full range of Medical Affairs professionals, from those leading or working in large organizations, to those tasked with starting a Medical Affairs function at startup or emerging organizations. Here, MAPS speaks with Lobna Salem, Regional Chief Medical officer Developed Markets& Japan Australia and New Zealand at Viatris, about the process of building Medical Affairs from scratch.
What is Medical Affairs and what does it do in the biopharmaceutical and MedTech industries? Who works in Medical Affairs and what skills do you need to succeed? Find out in this essential guide to understanding, joining and thriving in Medical Affairs.
At the MAPS 2022 Global Annual Meeting, MAPS sits down to chat with José Borbolla, Global Executive Medical Director at Esai, and Augusto Grinspan, VP Medical Affairs and Head LATAM with Merck KGaA about developments in the practice and direction of Medical Affairs in Latin America. Augusto and José are also co-chairs of the MAPS Latin America Chapter.